Early research (Phase 1)Active Not RecruitingNCT02852655
What this trial is testing
A Pilot Surgical Trial To Evaluate Early Immunologic Pharmacodynamic Parameters For The PD-1 Checkpoint Inhibitor, Pembrolizumab (MK-3475), In Patients With Surgically Accessible Recurrent/Progressive Glioblastoma
Who this might be right for
Brain Cancer
Dana-Farber Cancer Institute 60